Drug intelligence / Profile preview

Dynole-31-2

Development stage: Unknown
Lead developer: Children's Medical Research Institute
Modality: Small Molecules
Administration: In Vitro

Overview

Dynole-31-2 is a synthetic small-molecule tool compound used as a **negative control** for the dynamin inhibitor Dynole-34-2 in studies of clathrin-mediated endocytosis and dynamin function. It is built on the same chemical scaffold as Dynole-34-2 but lacks significant inhibitory activity against dynamin GTPase, allowing researchers to distinguish specific dynamin-dependent effects of Dynole-34-2 from scaffold-related or off-target effects in cellular assays. Dynole-31-2 is supplied for in vitro research use, typically dissolved in DMSO, and is not developed as a therapeutic agent.

Other names: Dynole 31-2Dynole31-2Dynole-31-2Dynole 31-2 negative controlDynole31-2 negative controlDynole-31-2 negative control

Beyond the preview

Go deeper on Dynole-31-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynole-31-2.

Explore the full profile